APA-viite (7. p.)

(15053003), T. W. C., (11929719), C. H., (15053006), R. H., (14954275), J. L., (15053009), K. C., (15053012), C. Y., . . . (15053027), C. Y. (2025). Supplementary Figure 4 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma.

Chicago-viite (17. p.)

(15053003), Tom Wei-Wu Chen, et al. Supplementary Figure 4 from A Single-Arm Phase Ib/II Study of Lenvatinib Plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma. 2025.

MLA-viite (9. p.)

(15053003), Tom Wei-Wu Chen, et al. Supplementary Figure 4 from A Single-Arm Phase Ib/II Study of Lenvatinib Plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma. 2025.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.